BIOHIT introduces the FAEX™ Sample System for stool sample collection and handling
BIOHIT introduces the FAEX™ Sample System for stool sample collection and handling
Biohit Oyj Press release 31 January 2025 at 11.30 am local time (EEST)
BIOHIT Oyj is excited to announce the launch of the BIOHIT FAEX Sample System, a revolutionary stool sample collection and handling solution that can be seamlessly incorporated into any diagnostic workflow. Designed for precision, efficiency and flexibility, this innovative, practical and reliable system addresses the needs of both patients and laboratories.
The BIOHIT FAEX Sample System combines multi-functionality with ease of use. It serves as both a standard test tube and a convenient dropper tube, enabling precise and reproducible sample dispensing for ELISAs, chemiluminescence assays, lateral flow tests and proprietary diagnostic kits. The precision-engineered collection stick ensures consistent and accurate sample collection, while a screw-tight cap with leak-proof threads promotes safe and hygienic handling, transport, storage and disposal.
CE-marked and compliant with Regulation (EU) 2017/746 for In Vitro Diagnostic Devices (IVDR), the BIOHIT FAEX Sample System meets the highest regulatory standards. Whether used as a standalone component or as part of a diagnostic kit, it is a versatile and efficient solution that simplifies stool sample collection and processing in any setting.
Jussi Hahtela, CEO of BIOHIT OYJ, commented: “The BIOHIT FAEX Sample System exemplifies our commitment to providing innovative solutions that address real-world challenges for patients and laboratories. By combining precision and efficiency, we are empowering customers to streamline their workflows and improve the patient experience. The unique adaptability of the BIOHIT FAEX Sample System makes it an excellent addition to our own and other manufacturers’ diagnostic kits, while also serving as a reliable standalone solution for laboratories.”
Visit https://www.biohithealthcare.com/en/products/biohit-faex-sample-system/ to find out more about the BIOHIT FAEX Sample System.
Jussi Hahtela, CEO, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohit.fi
Biohit in brief
Biohit Oyj is a Finnish biotechnology company that operates internationally. Biohit’s mission is Innovating for Health – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the United Kingdom. Biohit’s series B share (BIOBV) is listed on Nasdaq OMX Helsinki in the Small Cap/Healthcare group.